SQUARZONI, ANGELICA
SQUARZONI, ANGELICA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
STUDY OF THE EFFECT OF HISTONE DEACETYLASE INHIBITORS ON CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
2025 Squarzoni, A
Histone deacetylase 6 inhibitors and neuroprotection: evidences and molecular mechanisms
2024 Squarzoni, A; Donzelli, E; Rodriguez-Menendez, V; Cavaletti, G; Scuteri, A
Pharmacodynamic Drug-Drug Interaction Between Oxaliplatin and HDAC Inhibitors in Colorectal Cancer Cell Lines
2024 Squarzoni, A; Ette, M; Boleslav, B; Donzelli, E; Scuteri, A; Cavaletti, G; Donald, M
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY
2023 Squarzoni, A; Donzelli, E; Alberti, P; Ballarini, E; Rodriguez Menendez, V; Scuteri, A; Cavaletti, G
HDAC inhibitors as antineoplastic and neuroprotective drugs: in vitro assessment
2023 Squarzoni, A; Alberti, P; Donzelli, E; Scuteri, A; Cavaletti, G
Histone deacetylases inhibitors: a new frontier for neuroprotection?
2023 Squarzoni, A; Donzelli, E; Alberti, P; Ballarini, E; Rodriguez Menendez, V; Scuteri, A; Cavaletti, G
Exploiting the double-effect of HDACi as therapeutic tool against cancer
2022 Squarzoni, A; Donzelli, E; Alberti, P; Scuteri, A; Cavaletti, G
HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?
2022 Squarzoni, A; Scuteri, A; Cavaletti, G